1 Exhibit 10.1 *TEXT OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. SECTIONS 200.80(b)(4), 200.83 AND 240.24b-2. ABBOTT-RIBOGENE LICENSE AGREEMENT 2 Table of Contents5 License Agreement • May 20th, 1998 • Ribogene Inc / Ca/ • Services-commercial physical & biological research • New York
Contract Type FiledMay 20th, 1998 Company Industry Jurisdiction